News About RareCan & Rare Cancer Research

Raising the Profile of Granulosa Cell Tumour with the Survivor Sisters!

January 19, 2023

RareCan Member Linda was diagnosed with Adult Granulosa Cell Tumour in Jan 2007. Given the rarity of her cancer diagnosis, she is passionate about creating

RareCan, recognised as one of the most disruptive and innovative small businesses in the UK

January 10, 2023

15th annual Startups 100 celebrates best new UK businesses Previous companies listed include Monzo, Deliveroo, and HelloFreshRareCan listed on Annual Index of Disruptive UK Startups

RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme

November 8, 2022

RareCan, the UK’s only health tech company that specialises in supporting people with rare cancers, has been selected to join the prestigious KQ Labs programme

Research into Rare Cancers is Vital for Families like Mine in the Future

November 7, 2022

Knowing Paul’s cancer was fairly rare with little research into it made me feel frustrated and angry. He wanted to help find a cure and

1,000 Members and Growing!

August 24, 2022

The members of the RareCan community remain at the very heart of all we do Listen to Piers give an update on what it means

PARP inhibitors may prevent tumours in BRCA positive cancers

August 22, 2022

18th August 2022 – Rare Cancer in the News Professor Andy Hall looks at some recent news about the impact PARP inhibitors could have on

Star DJ and house music pioneer Sasha to play gig to help his Dad speed up Rare Cancer research

July 4, 2022

On Saturday 2nd July Sasha, will be taking a break from his current world tour to play a sell-out gig at the Gazelle Hotel in

RareCan Launches Crowdfunding Campaign

June 20, 2022

Hexham, UK, 21 June 2022: RareCan, a direct-to-patient clinical trial recruitment platform bringing together the power of patients and their data to reduce the costs

Sally’s Experience with Rare Cancer

April 14, 2022

During the Pandemic, I was diagnosed with a very rare and aggressive type of soft tissue cancer called angiosarcoma which was most likely caused by

Meeting our Members: Getting the GIST

March 28, 2022

In March 2022, Andy had the opportunity to present at the GIST Cancer UK annual patient and carer meeting and lead a discussion on ‘Patient

Latest news

Raising the Profile of Granulosa Cell Tumour with the Survivor Sisters!

RareCan, recognised as one of the most disruptive and innovative small businesses in the UK

RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme

Research into Rare Cancers is Vital for Families like Mine in the Future

1,000 Members and Growing!

PARP inhibitors may prevent tumours in BRCA positive cancers

Star DJ and house music pioneer Sasha to play gig to help his Dad speed up Rare Cancer research

RareCan Launches Crowdfunding Campaign

Sally’s Experience with Rare Cancer

Meeting our Members: Getting the GIST

Index

Resources

Social